News Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-02-07 am EST			5-day change	1st Jan Change
7,926.00 ^JPY	-1.02%		-2.58%	-7.84%

Feb. 07	Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year 2024	CI
Jan. 13	Otsuka Says US FDA to Hold Advisory Meeting for PTSD Treatment Combo	MT

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year 2024	Feb. 07	CI
Otsuka Says US FDA to Hold Advisory Meeting for PTSD Treatment Combo	Jan. 13	MT
Final dividend	Dec. 26	FA
Otsuka Completes Share Repurchase Program	Nov. 26	MT
Tranche Update on Otsuka Holdings Co., Ltd.'s Equity Buyback Plan announced on August 1, 2024.	Nov. 26	CI
Otsuka Holdings Co., Ltd.'s Equity Buyback announced on August 1, 2024 has closed with 5,810,900 shares, representing 1.07% for ¥49,882.99 million.	Nov. 21	CI
Nikkei Slips as Beijing's Property Support Measures Fail to Lift Sentiment	Nov. 14	MT
Otsuka, ICU Medical Launch Joint Venture in North America	Nov. 13	MT
Otsuka : Message from Tatsuo Higuchi, President and Representative Director, CEO	24-10-31	PU
Otsuka : Message from Makoto Inoue, Representative Director, COO	24-10-31	PU
Otsuka Holdings Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. Announces Changes of Representative Director	24-10-31	CI
Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	24-10-31	CI
Otsuka Holdings Co., Ltd. Announces CEO Changes	24-10-31	CI
Otsuka Holdings Reports Phase 3 Trial Results for Sibeprenlimab in IgA Nephropathy	24-10-22	MT
Jefferies Adjusts Otsuka Holdings' Price Target to 10,500 Yen From 9,700 Yen, Keeps at Buy	24-10-18	MT
Irlab receives milestone payment of USD 2.5 million linked to Phase 1 study with IRL757	24-10-08	FW
IRLAB Therapeutics AB Announces Positive Data from the First Part of Phase I Study with the Drug Candidate IRL 757	24-10-03	CI
Tranche Update on Otsuka Holdings Co., Ltd.'s Equity Buyback Plan announced on August 1, 2024.	24-10-01	CI
Japanese Shares Fall into Red After Four-Day Rally Despite China's Stimulus Package	24-09-25	MT
Otsuka Pharmaceutical Secures Additional Indication for Rexulti in Japan	24-09-24	MT
Jefferies Adjusts Otsuka Holdings' Price Target to 9,700 Yen From 9,300 Yen, Keeps at Buy	24-08-27	MT
Jefferies Adjusts Otsuka Holdings' Price Target to 9,300 Yen From 8,600 Yen, Keeps at Buy	24-08-19	MT
Otsuka's Profit Up 5% in Fiscal H1	24-08-02	MT
Global markets live: Shell, Chevron, Boeing, Walt Disney, Qualcomm...	24-08-01
Japan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics	24-08-01	RE

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Pharmaceuticals

Filters